Epstein Secrets

focus on for investment in the Fund include: • Western Europe (e.g., UK, Ireland, Germany, France, Netherlands) • Northern Europe (e.g., Sweden, Finland, Denmark, Estonia) • North America (e.g., Canada, US (ex-Northern California)) Examples of geographies where Valar is open to inbound deal flow th

ples of geographies Valar does not intend to focus on for the Fund: • China, India, Russia, Brazil, Turkey, Africa, Latin America, the Middle East, Southeast Asia Investor Value Add: As noted above, the best founders understand the importance of receiving investment from the most reputable venture firms. Unli

of wars, was in Europe. The principal war there began in 1939, and related wars by the Soviet Union (joining Germany against Poland, then attacking Finland) and by Italy (against Albania, then Greece). A decisive campaign in the European war had concluded with the surprising defeat of France in the summ

he European war had concluded with the surprising defeat of France in the summer of 1940 — which led to further Japanese expansion that summer into Southeast Asia. Where Week 10 ends is with the world as it has been transformed by these wars, the culmination of a decade of crises. By the time we conclude the

> President Liberia EFTA00774867 71 Tarja Halonen <http://www.forbes.com/lists/2008/11/biz_powerwomen08_Tarja-Halonen_6T1X .html> President Finland RANK <http://www.forbes.com/lists/2008/11/biz_powerwomen08_The-100-Most-Power ful-WomenRank.html> NAME <http://www.forbes.com/lists/2008/11/biz_

utive, Areva France 88 Eva Cheng <http://www.forbes.com/lists/2008/11/biz_powerwomen08_Eva-Cheng_34MT.htm 1> Chief executive, Greater China and Southeast Asia, Amway China 85 Clara Furse <http://www.forbes.comilists/2008/11/biz_powerwomen08_Clara-Furse_XX2S.h tml> Chief executive, London Stock Exchang

0 printing for individualized mass production of biomechanically optimized insoles. Airborne Oil & Gas Bmulden (Netherlands) Synoste Oy Espoo (Finland) Strategic focus on the following Evonik competencies An excellent strategic fit with Evonik's expertise in biotechnology and delivery systems fo

s in Midrand (South Africa) and Singapore to develop product solutions specifically for customers in the personal care sector in Subsaharan Africa, Southeast Asia, Australia and New Zealand. Similarly, the Health Care Busi- ness Line started to build up a worldwide network of service laboratories for medical